Research Studies
Back to Results
An Open-Label, Multicenter, First-in-Human, Dose-Escalation Phase 1 Study of INBRX-109 in Subjects with Locally Advanced or Metastatic Solid Tumors Including Sarcomas
Details
Age
Adult
Eligibility
expansion is limited to malignant pleural mesothelioma, gastric adenocarcinoma and colorectal adenocarcinoma
Phase
I - Research Studies that focus on the safety of a drug. The goal is to determine the drug's most frequent and serious adverse events and, often, how the drug is broken down and excreted by the body. These studies usually involve a small number of participants.
Type of Study
Treatment
Location
University of Colorado Hospital
Principal Investigator
Chris Lieu, MD
Study ID
Protocol Number: 18-1672
ClinicalTrials.gov: NCT03715933
Categories
Is this Study for You?
Not finding the right Study for you? Join ResearchMatch, a nation-wide registry connecting volunteers and researchers